RecruitingNot ApplicableNCT06615609

"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients

Sponsor

China National Center for Cardiovascular Diseases

Enrollment

536 participants

Start Date

Sep 24, 2025

Study Type

INTERVENTIONAL

Conditions

Diabetes Mellitus Hypertension Hyperlipidemia Post Coronary Artery Bypass Grafting Post PCI

Summary

This study aims to evaluate the effect of an AI-assisted "Smart family doctor" digital health management tool on improving the control rates of hypertension, diabetes, and dyslipidemia in post-CABG (coronary artery bypass grafting) patients or post-PCI (percutaneous coronary intervention) patients. A randomized controlled trial design will be used, involving approximately 5-10 hospitals and 536 participants. Eligible participants are adults aged 18 or older, post-CABG or post-PCI patients with hypertension, diabetes, and dyslipidemia.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether a "Smart Family Doctor" AI-assisted digital tool can help people who have had heart bypass surgery (CABG) or a stent procedure (PCI) better manage their blood pressure, blood sugar, and cholesterol — all key risk factors for another heart event. **You may be eligible if...** - You are 18 years old or older - You have had CABG or PCI surgery - You also have at least one of: hypertension, diabetes, or high cholesterol - Your blood pressure, blood sugar (HbA1c), or LDL cholesterol is above target levels - You own and can use a smartphone **You may NOT be eligible if...** - You have had a recent major cardiovascular event (within 3 months) - You have severe heart failure or kidney disease - You are unable to use a smartphone - You are enrolled in another cardiovascular clinical trial Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSmart family doctor

Based on health managers, participants were additionally provided "Smart family doctor", which is an AI-assisted applications with personalized interactions. The content includes, but is not limited to: (1) General educational content, covering basic health knowledge on diseases, risk factors, and treatment methods; (2) Targeted health information, such as more specific guidance on blood pressure and blood sugar control, medication adherence, exercise, and smoking cessation; (3) Personalized disease management guidance, providing tailored reminders for patients regarding medication, diet, exercise, and medical visits. Patients can also directly report their latest self-measured blood pressure, blood lipid, blood sugar levels, and medication adherence to receive treatment and medication guidance from the 'Smart family doctor'.

BEHAVIORALHealth manager

Participants will received 3-hour health management guidance from a health manager once a week, including guidance on healthy lifestyle, medication treatment, and rehabilitation advice. The research team will provide participants with one smart band, requiring them to wear the band daily to collect health data during the 6-month study period.

Locations(1)

Xinjiang's First Affiliated Hospital of medical university

Ürümqi, Xinjiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06615609

Related Trials

Hypertension Management in Young Adults Personalised by Echocardiography and Clinical Outcome.

NCT037624991 location

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

NCT070644731152 locations